CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 



Ziopharm Oncology Inc  (ZIOP)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
 
 

Ziopharm Oncology Inc Growth Comparisons

Select each growth Category to receive further Information

Select the Comparisons : Select the Ratio:                        

ZIOP Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) -18.89 % 0.55 % -1.56 % 5.92 %
Q / Q Revenue Growth (Q1 MRQ) 0 % 4.41 % 1.71 % -4.7 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 57.88 % -5.01 % 1.76 % %
Seq. Revenue Growth (for 12 months ending Q1 TTM) -5.42 % 0.31 % -0.67 % 2.35 %
Revenue 5 Year Average Growth 59.39 % 21.3 % 9.82 % 14.44 %
Expected Revenue Growth (Y/Y) - - 1.89 % 2.71 %


ZIOP's Growth Comparisons in I. Quarter 2017


You need to upgrade your Flash Player


Ziopharm Oncology Inc's sharp decrease of -18.89% in sales in the first quarter from the same quarter a year ago, those results deviated strongly from rising Revenue in Healthcare Facilities industry with 0.55%, and underperformed the -1.56% Revenue decrease in the Healthcare sector. Weak first quarter sales, in Healthcare Facilities industry and within the Healthcare sector, were reflected in Ziopharm Oncology Inc results which underperformed overall market.

Sequentially company's Revenue were unchanged from the forth quarter results. . Looking into annual growth, sales grew by 59.39% on average in last five years, while S & P 500's including only Businesses with the first quarter 2017 earnings reports, average yearly sales growth is 14.44%.


Growth Rates of ZIOP's Income in the first quarter 2017


ZIOP Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - 2.4 % -0.58 % 32.7 %
Seq. Operating Income Change (Q1 MRQ) - 1.13 % 44.7 % 9.17 %
Y / Y Operating Income Growth (Q1 TTM) - 27.58 % 6.98 % 26.47 %
Seq. Operating Income Growth (Q1 TTM) - 0.51 % -1.96 % 22.26 %
Operating Income 5 Year Avg. Change - -5.54 % -0.83 % 13.42 %

Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - 5.25 % -8.93 % 24.97 %
Seq. Income from Cont. Ops. Change (Q1 MRQ) - -0.33 % 122.86 % 20.34 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - -23.86 % -12.1 % 9.63 %
Seq. Income from Cont. Ops. Change (Q1 TTM) - 2.2 % -6.64 % 6.18 %
Income from Cont. Ops. 5 Year Avg. Change - 13.11 % 1.3 % 15.81 %

ZIOP Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - 5.39 % -10.93 % 19.85 %
Q / Q Net Income Growth (Q1 MRQ) - 2.77 % 100.2 % 15.8 %
Y / Y Net Income Change (Q1 TTM) - -29.81 % 1.15 % 11.3 %
Seq. Net Income Change (Q1 TTM) - -3.6 % -6.21 % 5.16 %
Net Income 5 Year Avg. Growth - 12.3 % 4.52 % 15.79 %

ZIOP's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - 0.02 % -8.93 % 24.97 %
Seq. EPS from Cont. Ops. Change (Q1 MRQ) - -1.4 % 122.86 % 20.34 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - -34.91 % - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) - -3.23 % - 7.54 %
EPS from Cont. Ops. 5 Year Avg. Growth - -10.46 % 1.3 % 15.81 %

You need to upgrade your Flash Player

ZIOP EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - 0.15 % -10.93 % 15.81 %
Q / Q EPS Net Growth (Q1 MRQ) - 1.67 % 100.2 % 15.8 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - -47.31 % - 19.43 %
Seq. EPS Net Change (for 12 months ending Q1 TTM) - -23.18 % - 7.35 %
EPS Net 5 Year Avg. Change - 12.3 % 4.52 % 15.79 %
Expected EPS Growth (Y/Y) - - 123.59 % 29.33 %



Ziopharm Oncology Inc reported bottom-line of $ -0.15 in the first quarter, compare to $ -0.09 in the same quarter a year ago. Healthcare Facilities industry grew by 0.15%, while Healthcare sector decreased by -10.93%, and overall market improved by 19.85%.

Sequentially company's EPS were unchanged from the forth quarter results. . Looking into annual growth, income per share grew by 59.39% on average in last five years, while S & P 500's including only Businesses with the first quarter 2017 financial results, average yearly income per share growth is 15.79%.

ZIOP Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - 20.76 % 14.6 % 1.59 %
Seq. Free Cash Flow Change (Q1 MRQ) - 67.28 % -31.38 % -48.92 %
Y / Y Free Cash Flow Change (Q1 TTM) - 7.43 % 8.17 % -0.08 %
Seq. Free Cash Flow Change (Q1 TTM) - 1.88 % -1.45 % -3.82 %
Free Cash Flow 5 Year Avg. Change - 73.6 % 5.22 % 16.16 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - 217.07 % - -25.65 %
Seq. Net Cash Flow Change (Q1 MRQ) - - -81.01 % -
Y / Y Net Cash Flow Change (Q1 TTM) - 1213.43 % 200.73 % -3.75 %
Seq. Net Cash Flow Change (Q1 TTM) - 26.46 % 70.37 % -14.2 %
Net Cash Flow 5 Year Avg. Change - - -17.31 % 34.83 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 128.03 % -7.73 % 19.25 % 0.88 %
Seq. Capital Expenditures Change (Q1 MRQ) 336.59 % -31.98 % -32.71 % -37.39 %
Y / Y Capital Expenditures Change (Q1 TTM) 36.23 % 3.93 % 11.83 % -1.42 %
Seq. Capital Expenditures Change (Q1 TTM) 36.48 % -1.48 % 2.87 % -3.67 %
Capital Expenditures 5 Year Avg. Change - -78.13 % -73.95 % -67.94 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com